Skip to main content
Top
Published in: Arthritis Research & Therapy 1/1999

01-12-1999 | Paper Report

Functional heterogeneity of osteoclasts

Author: Fraser Coxon

Published in: Arthritis Research & Therapy | Issue 1/1999

Login to get access

Excerpt

Osteoclasts, the multinucleated cells responsible for the degradation of mineralized matrices, are thought to resorb bone by a common mechanism, despite differences in bone matrix composition. However, certain bone diseases, in which defects in resorption occur at specific sites, such as craniometaphyseal dysplasia, raise the possibility that the mechanism of osteoclastic resorption may itself be site-specific. Cysteine proteinases (CPs), particularly cathepsin K, are essential for bone resorption, whereas matrix metalloproteinases (MMPs) are involved in resorption in calvarial tissue explants, but not in resorption by isolated osteoclasts. Since the latter usually involves the use of osteoclasts isolated from long bones, it is possible that resorption by osteoclasts from different sites may utilize different proteinases. To investigate whether osteoclasts from calvarial and long bones differ in their resorptive mechanism and, if so, whether these differences are related to the substratum that they resorb. …
Literature
1.
go back to reference Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJ, Beertsen W: Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 1999, 13: 1219-1230.PubMed Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJ, Beertsen W: Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 1999, 13: 1219-1230.PubMed
Metadata
Title
Functional heterogeneity of osteoclasts
Author
Fraser Coxon
Publication date
01-12-1999
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/1999
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar-1999-66735

Other articles of this Issue 1/1999

Arthritis Research & Therapy 1/1999 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine